Board of Scientific Counselors, National Center for Health Marketing (BSC, NCHM), 28710-28711 [E9-14213]

Download as PDF 28710 Federal Register / Vol. 74, No. 115 / Wednesday, June 17, 2009 / Notices of the remaining databases, and because they are not amenable to automated searching or have more limited automated searching capabilities than others, FDA understands that there may be some overlap across some of the databases and/or some limitation to automated search capabilities. However, as discussed in section IV.A.3. of the concept paper, the majority of names with similarity to the proposed proprietary name can be identified through database searches, and a variety of publicly available databases and resources containing product names can be used to identify similar names. FDA itself uses databases, the Internet, and other printed and electronic drug product resources to search for orthographic and phonological name similarities. The concept paper recommends that applicants search a variety of sources and, at a minimum, search the publicly available databases listed in Appendix A of the concept paper ‘‘Computerized Resources’’ because these databases are ones that FDA itself uses and considers the information in these references useful screening tools if properly searched. If a name appears in more than one database, it is acceptable to list the name once and list the sources along with the identified name. In addition, in most cases, the computerized resources listed in Appendix A are publicly available, including the Phonetic Orthographic Computer Analysis (POCA) software (see FDA’s notice of availability in the Federal Register of February 17, 2009 (74 FR 7450). As part of the pilot program, FDA encourages sponsors to identify any new databases or those databases which are more amenable to automated searching. FDA estimates the burden of this collection of information in table 1 of this document. The ‘‘Hours Per Response’’ is for all of the submissions and notifications to FDA described previously under paragraphs 1 to 4 in this document, and is based on information provided by industry as well as FDA’s familiarity with the time required for this information collection as follows: TABLE 1.—ESTIMATED ANNUAL REPORTING BURDEN1 Number of Respondents Pilot Project Proprietary Name Review 1 There Number of Responses per Respondent 20 1 Hours Per Response 20 Total Hours 480 9,600 are no capital costs or operating and maintenance costs associated with this collection of information. Dated: June 11, 2009. Jeffrey Shuren, Associate Commissioner for Policy and Planning. [FR Doc. E9–14212 Filed 6–16–09; 8:45 am] BILLING CODE 4160–01–S DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Mental Health; Notice of Closed Meetings dwashington3 on PROD1PC60 with NOTICES Total Annual Responses Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of meetings of the National Advisory Mental Health Council. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Advisory Mental Health Council. Date: July 17, 2009. Time: 1 p.m. to 5 p.m. Agenda: To review and evaluate grant applications. VerDate Nov<24>2008 15:33 Jun 16, 2009 Jkt 217001 Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Conference Room D, Rockville, MD 20852. (Telephone Conference Call). Contact Person: Jane A. Steinberg, PhD, Director, Division of Extramural Activities, National Institute of Mental Health, NIH, Neuroscience Center, 6001 Executive Blvd., Room 6154, MSC 9609, Bethesda, MD 20892– 9609. 301–443–5047. Name of Committee: National Advisory Mental Health Council. Date: August 14, 2009. Time: 12 p.m. to 3 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Conference Room D, Rockville, MD 20852. (Telephone Conference Call). Contact Person: Jane A. Steinberg, PhD, Director, Division of Extramural Activities, National Institute of Mental Health, NIH, Neuroscience Center, 6001 Executive Blvd., Room 6154, MSC 9609, Bethesda, MD 20892– 9609. 301–443–5047. Name of Committee: National Advisory Mental Health Council. Date: September 9, 2009. Time: 1 p.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Conference Room D, Rockville, MD 20852. (Telephone Conference Call). Contact Person: Jane A. Steinberg, PhD, Director, Division of Extramural Activities, National Institute of Mental Health, NIH, Neuroscience Center, 6001 Executive Blvd., Room 6154, MSC 9609, Bethesda, MD 20892– 9609. 301–443–5047. PO 00000 Frm 00048 Fmt 4703 Sfmt 4703 Information is also available on the Institute’s/Center’s home page: https:// www.nimh.nih.gov/about/advisory-boardsand-groups/namhc/index.shtml, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.242, Mental Health Research Grants; 93.281, Scientist Development Award, Scientist Development Award for Clinicians, and Research Scientist Award; 93.282, Mental Health National Research Service Awards for Research Training; 93.701, ARRA Related Biomedical Research and Research Support Awards., National Institutes of Health, HHS) Dated: June 9, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–14087 Filed 6–16–09; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Board of Scientific Counselors, National Center for Health Marketing (BSC, NCHM) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), CDC announces the following meeting of the aforementioned committee: Times and Dates: 9 a.m.–5 p.m., July 14, 2009. E:\FR\FM\17JNN1.SGM 17JNN1 dwashington3 on PROD1PC60 with NOTICES Federal Register / Vol. 74, No. 115 / Wednesday, June 17, 2009 / Notices 8:30 a.m.–1 p.m., July 15, 2009. Place: CDC, 1600 Clifton Road, NE., Building 19, Room 256/257, Atlanta, Georgia 30333. Status: Open to the public, limited only by the space available. The meeting room accommodates approximately 60 people. Purpose: The Secretary, Department of Health and Human Services (HHS), and, by delegation, the Director, Centers for Disease Control and Prevention (CDC), are authorized under Section 301 (42 U.S.C. 241) and Section 311 (42 U.S.C. 243) of the Public Health Service Act (PHSA), as amended to: develop and implement disease prevention and control, environmental health, and health promotion and health education activities designed to improve the health of the people of the United States. Under these and additional PHSA and other authorities, CDC acts by identifying and defining preventable health problems; maintaining active surveillance of diseases through epidemiologic and laboratory investigations and data collection, analysis, and distribution; conducting operational research aimed at developing and testing effective disease prevention, control, and health promotion programs; administering a national occupational safety and health program; controlling the introduction and spread of infectious diseases; and providing consultation and assistance to other nations and international agencies to assist in improving their disease prevention and control, environmental health, and health promotion activities. CDC carries out these functions through a number of Coordinating Centers/ Offices and National Centers and Institutes with expertise and responsibilities in specific areas. Matters to be Discussed: The agenda will include discussions regarding two topics on which the BSC decided to focus its reviews: (1) Discovery activities (i.e., generation of knowledge, science and research); and (2) Diffusion activities (i.e., translation and transfer of knowledge to practice). Agenda items are tentative and subject to change. Contact Person for More Information: Dionne R. Mason, Committee Management Specialist, NCHM, 1600 Clifton Road, NE., Mail Stop E–21, Atlanta, Georgia 30333, Telephone: (404) 498–2314, Fax (404) 498–2221. The deadline for notification of attendance is June 30, 2009. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both CDC and VerDate Nov<24>2008 15:33 Jun 16, 2009 Jkt 217001 the Agency for Toxic Substances and Disease Registry. Dated: June 10, 2009. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC). [FR Doc. E9–14213 Filed 6–16–09; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HOMELAND SECURITY U.S. Customs and Border Protection Agency Information Collection Activities: Certificate of Registration AGENCY: U.S. Customs and Border Protection, Department of Homeland Security. ACTION: 30-Day Notice and request for comments; Extension of an existing information collection: 1651–0010. SUMMARY: U.S. Customs and Border Protection (CBP) of the Department of Homeland Security has submitted the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act: Certificate of Registration. This is a proposed extension of an information collection that was previously approved. CBP is proposing that this information collection be extended with no change to the burden hours. This document is published to obtain comments from the public and affected agencies. This proposed information collection was previously published in the Federal Register (74 FR 16226) on April 9, 2009, allowing for a 60-day comment period. This notice allows for an additional 30 days for public comments. This process is conducted in accordance with 5 CFR 1320.10. DATES: Written comments should be received on or before July 17, 2009. ADDRESSES: Interested persons are invited to submit written comments on the proposed information collection to the Office of Information and Regulatory Affairs, Office of Management and Budget. Comments should be addressed to the OMB Desk Officer for Customs and Border Protection, Department of Homeland Security, and sent via electronic mail to oira_submission@omb.eop.gov or faxed to (202) 395–5806. SUPPLEMENTARY INFORMATION: U.S. Customs and Border Protection (CBP) encourages the general public and affected Federal agencies to submit PO 00000 Frm 00049 Fmt 4703 Sfmt 4703 28711 written comments and suggestions on proposed and/or continuing information collection requests pursuant to the Paperwork Reduction Act (Pub. L. 104– 13). Your comments should address one of the following four points: (1) Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency/component, including whether the information will have practical utility; (2) Evaluate the accuracy of the agencies/components estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (3) Enhance the quality, utility, and clarity of the information to be collected; and (4) Minimize the burden of the collections of information on those who are to respond, including the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. Title: Certificate of Registration. OMB Number: 1651–0010. Form Number: Forms 4455 and 4457. Abstract: The Certificate of Registration is used to expedite free entry or entry at a reduced rate on foreign made personal articles that are taken abroad. The articles are dutiable each time they are brought into the United States unless there is acceptable proof of prior possession. It is also used for the registration, examination, and supervised lading of commercial shipments of articles exported for repair, alteration, processing, etc., which will subsequently be returned to the United States either free of duty or at a reduced rate. Current Actions: There are no changes to the information collection. This submission is being made to extend the expiration date. Type of Review: Extension (without change). Affected Public: Individuals, Travelers. Estimated Number of Respondents: 200,000. Estimated Number of Total Annual Responses: 200,000. Estimated Time Per Response: 3 minutes. Estimated Total Annual Burden Hours: 10,000. If additional information is required contact: Tracey Denning, U.S. Customs and Border Protection, Office of Regulations and Rulings, 799 9th Street, NW., 7th Floor, Washington, DC 20229– 1177, at 202–325–0265. E:\FR\FM\17JNN1.SGM 17JNN1

Agencies

[Federal Register Volume 74, Number 115 (Wednesday, June 17, 2009)]
[Notices]
[Pages 28710-28711]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-14213]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Board of Scientific Counselors, National Center for Health 
Marketing (BSC, NCHM)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), CDC announces the following meeting of 
the aforementioned committee:
    Times and Dates:
    9 a.m.-5 p.m., July 14, 2009.

[[Page 28711]]

    8:30 a.m.-1 p.m., July 15, 2009.
    Place: CDC, 1600 Clifton Road, NE., Building 19, Room 256/257, 
Atlanta, Georgia 30333.
    Status: Open to the public, limited only by the space available. 
The meeting room accommodates approximately 60 people.
    Purpose: The Secretary, Department of Health and Human Services 
(HHS), and, by delegation, the Director, Centers for Disease Control 
and Prevention (CDC), are authorized under Section 301 (42 U.S.C. 241) 
and Section 311 (42 U.S.C. 243) of the Public Health Service Act 
(PHSA), as amended to: develop and implement disease prevention and 
control, environmental health, and health promotion and health 
education activities designed to improve the health of the people of 
the United States. Under these and additional PHSA and other 
authorities, CDC acts by identifying and defining preventable health 
problems; maintaining active surveillance of diseases through 
epidemiologic and laboratory investigations and data collection, 
analysis, and distribution; conducting operational research aimed at 
developing and testing effective disease prevention, control, and 
health promotion programs; administering a national occupational safety 
and health program; controlling the introduction and spread of 
infectious diseases; and providing consultation and assistance to other 
nations and international agencies to assist in improving their disease 
prevention and control, environmental health, and health promotion 
activities. CDC carries out these functions through a number of 
Coordinating Centers/Offices and National Centers and Institutes with 
expertise and responsibilities in specific areas.
    Matters to be Discussed: The agenda will include discussions 
regarding two topics on which the BSC decided to focus its reviews: (1) 
Discovery activities (i.e., generation of knowledge, science and 
research); and (2) Diffusion activities (i.e., translation and transfer 
of knowledge to practice). Agenda items are tentative and subject to 
change.
    Contact Person for More Information: Dionne R. Mason, Committee 
Management Specialist, NCHM, 1600 Clifton Road, NE., Mail Stop E-21, 
Atlanta, Georgia 30333, Telephone: (404) 498-2314, Fax (404) 498-2221. 
The deadline for notification of attendance is June 30, 2009.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities for 
both CDC and the Agency for Toxic Substances and Disease Registry.

    Dated: June 10, 2009.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention (CDC).
[FR Doc. E9-14213 Filed 6-16-09; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.